QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
$14.40
$14.63
$11.95
$15.45
N/AN/A142,403 shs111,536 shs
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
$0.01
-14.2%
$0.02
$0.01
$0.06
$601K-0.3723,950 shs1,626 shs
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
$35.14
-0.5%
$35.65
$0.00
$0.00
$259.34M0.48N/A2,389 shs
GRI Bio, Inc. stock logo
GRI
GRI Bio
0.53
+2.0%
0.78
0.50
115.50
$1.69M-1.77625,344 shs424,131 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
+0.70%+1.98%-4.32%-0.76%+15.57%
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
+16.53%+16.53%0.00%-42.91%-68.31%
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
-0.13%-1.60%-1.24%+1.89%+12.82%
GRI Bio, Inc. stock logo
GRI
GRI Bio
+1.45%+1.45%-31.52%-72.62%+51,739,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
3.233 of 5 stars
3.04.00.00.03.80.80.0
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
N/AN/AN/AN/AN/AN/AN/AN/A
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
N/AN/AN/AN/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
2.00
Hold$52.50264.58% Upside
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
N/AN/AN/AN/A
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
0.00
N/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
$36.81MN/AN/AN/AN/AN/A
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
$190K3.16N/AN/A($0.05) per share-0.24
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
N/AN/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/A0.40 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
-$1.70M-$0.04N/AN/A-879.28%N/A-100.71%N/A
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
N/AN/A23.44N/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$13.04M-81.48N/AN/AN/A-795.54%-345.37%5/20/2024 (Estimated)

Latest CAPC, DJAN, AIF, HLCL, and GRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/29/2024Q4 2023
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
N/A-$0.01-$0.01-$0.01N/A$0.10 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
$1.5110.49%+15.51%N/A2 Years
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
N/AN/AN/AN/AN/A
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
N/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/AN/A

Latest CAPC, DJAN, AIF, HLCL, and GRI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/12/2024
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
Monthly$0.144012.33%4/22/20244/23/20244/30/2024
3/11/2024
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
Monthly$0.138011.04%3/20/20243/21/20243/28/2024
2/9/2024
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
Monthly$0.133010.99%2/21/20242/22/20242/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
N/AN/AN/A
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
N/A
0.02
0.02
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
N/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/A
1.09
1.09

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apollo Tactical Income Fund Inc. stock logo
AIF
Apollo Tactical Income Fund
N/AN/AN/ANot Optionable
Capstone Companies, Inc. stock logo
CAPC
Capstone Companies
549.64 million29.79 millionNot Optionable
DJAN
FT Vest U.S. Equity Deep Buffer ETF - January
N/A7.38 millionN/ANot Optionable
GRI Bio, Inc. stock logo
GRI
GRI Bio
13.20 million2.66 millionNot Optionable

CAPC, DJAN, AIF, HLCL, and GRI Headlines

SourceHeadline
GRI Bio, Inc.: GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentGRI Bio, Inc.: GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
finanznachrichten.de - April 18 at 7:33 PM
GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentGRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
globenewswire.com - April 16 at 8:35 AM
GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceGRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
globenewswire.com - April 8 at 8:35 AM
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate UpdateGRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
globenewswire.com - April 1 at 7:35 AM
Tamil Nadu Newsprint & Papers Share PriceTamil Nadu Newsprint & Papers Share Price
business-standard.com - March 28 at 7:19 PM
Steven Ehrlich donates professional archive to Architecture and Design Collection at UCSB’s AD&A MuseumSteven Ehrlich donates professional archive to Architecture and Design Collection at UCSB’s AD&A Museum
archpaper.com - March 28 at 7:19 PM
GRI Bio to Present at the MedInvest Biotech & Pharma Investor ConferenceGRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference
globenewswire.com - March 28 at 9:00 AM
UCSB Art Museum Collection adds Archive of Modernist Architect Steven EhrlichUCSB Art Museum Collection adds Archive of Modernist Architect Steven Ehrlich
noozhawk.com - March 18 at 9:11 PM
Prominent Modernist Steven Ehrlich Adds Architectural Archives to UC Santa Barbara Art MuseumProminent Modernist Steven Ehrlich Adds Architectural Archives to UC Santa Barbara Art Museum
independent.com - March 15 at 8:03 PM
GRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsGRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
finanznachrichten.de - March 14 at 1:50 PM
GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
finance.yahoo.com - March 14 at 8:50 AM
GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators
globenewswire.com - March 14 at 8:45 AM
GRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomGRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
finanznachrichten.de - March 4 at 12:43 PM
GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomGRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
globenewswire.com - March 4 at 8:30 AM
Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)
benzinga.com - February 23 at 7:50 AM
GRI Bio: Entry Into A Material Definitive Agreement, Other EventsGRI Bio: Entry Into A Material Definitive Agreement, Other Events
cbonds.com - February 5 at 2:06 PM
GRI Bio Launches Major Securities Public OfferingGRI Bio Launches Major Securities Public Offering
msn.com - February 3 at 2:55 PM
GRI Bio prices 5M shares at $1.10 in public offeringGRI Bio prices 5M shares at $1.10 in public offering
msn.com - February 2 at 12:29 PM
GRI Bio Shares Drop After Stock Offering Prices Below Thursdays CloseGRI Bio Shares Drop After Stock Offering Prices Below Thursday's Close
marketwatch.com - February 2 at 12:29 PM
GRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock DownGRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock Down
markets.businessinsider.com - February 2 at 12:29 PM
Why Is GRI Bio (GRI) Stock Down 21% Today?Why Is GRI Bio (GRI) Stock Down 21% Today?
investorplace.com - February 2 at 11:07 AM
Samsung Galaxy Fit3 tüm ayrıntılarıyla belli oldu: İşte özellikleriSamsung Galaxy Fit3 tüm ayrıntılarıyla belli oldu: İşte özellikleri
donanimhaber.com - January 31 at 12:56 PM
GRI Bio, Inc.: GRI Bio Announces Reverse Stock SplitGRI Bio, Inc.: GRI Bio Announces Reverse Stock Split
finanznachrichten.de - January 26 at 7:25 PM
GRI Bios board OKs 1-for-7 reverse stock splitGRI Bio's board OKs 1-for-7 reverse stock split
msn.com - January 26 at 7:25 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apollo Tactical Income Fund logo

Apollo Tactical Income Fund

NYSE:AIF
Apollo Tactical Income Fund Inc. is a closed-ended fixed income fund launched and managed by Apollo Credit Management, LLC. The fund invests in fixed income markets. It primarily invests in senior secured loans including floating rate senior loans, high yield corporate bonds, and other credit instruments of varying maturities made to companies whose debt is typically rated below investment grade. The fund employs a conservative approach to credit selection that focuses on such factors as collateral coverage, structural seniority, credit fundamentals, with emphasis on leading defensible market positions, stable companies with positive cash flow, and proven management teams to create its portfolio. Apollo Tactical Income Fund Inc. was formed on February 25, 2013 and is domiciled in the United States.
Capstone Companies logo

Capstone Companies

OTCMKTS:CAPC
Capstone Companies, Inc., through its subsidiaries, engages in the development, marketing, and sale of consumer home light-emitting diode (LED) lighting products for indoor and outdoor applications worldwide. Its lighting products include connected surfacessmart mirrors and standard rectangular wardrobe/fitness mirrors. The company markets its products under the Capstone Lighting brand name, as well as under the Hoover Home LED brand through a network of direct sales force, retailers, and distributors. It sells its products through e-commerce websites. The company was formerly known as CHDT Corporation and changed its name to Capstone Companies, Inc. in June 2012. Capstone Companies, Inc. is headquartered in Deerfield Beach, Florida.

FT Vest U.S. Equity Deep Buffer ETF - January

BATS:DJAN
The FT Cboe Vest U.S. Equity Deep Buffer ETF - January (DJAN) is an exchange-traded fund that is based on the SPDR S&P 500 ETF Trust index. The fund aims for specific buffered losses and capped gains on SPY ETF over a specific holdings period. The actively-managed fund holds options and collateral. DJAN was launched on Jan 15, 2021 and is managed by First Trust.
GRI Bio logo

GRI Bio

NASDAQ:GRI
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.